193 related articles for article (PubMed ID: 30001928)
1. Sensitivity and clinical utility of the anti-cytosolic 5'-nucleotidase 1A (cN1A) antibody test in sporadic inclusion body myositis: Report of 40 patients from a single neuromuscular center.
Felice KJ; Whitaker CH; Wu Q; Larose DT; Shen G; Metzger AL; Barton RW
Neuromuscul Disord; 2018 Aug; 28(8):660-664. PubMed ID: 30001928
[TBL] [Abstract][Full Text] [Related]
2. Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.
Larman HB; Salajegheh M; Nazareno R; Lam T; Sauld J; Steen H; Kong SW; Pinkus JL; Amato AA; Elledge SJ; Greenberg SA
Ann Neurol; 2013 Mar; 73(3):408-18. PubMed ID: 23596012
[TBL] [Abstract][Full Text] [Related]
3. Pathomechanisms of anti-cytosolic 5'-nucleotidase 1A autoantibodies in sporadic inclusion body myositis.
Tawara N; Yamashita S; Zhang X; Korogi M; Zhang Z; Doki T; Matsuo Y; Nakane S; Maeda Y; Sugie K; Suzuki N; Aoki M; Ando Y
Ann Neurol; 2017 Apr; 81(4):512-525. PubMed ID: 28318044
[TBL] [Abstract][Full Text] [Related]
4. Anti-cN1A antibodies do not correlate with specific clinical, electromyographic, or pathological findings in sporadic inclusion body myositis.
Paul P; Liewluck T; Ernste FC; Mandrekar J; Milone M
Muscle Nerve; 2021 Apr; 63(4):490-496. PubMed ID: 33373040
[TBL] [Abstract][Full Text] [Related]
5. Determination of cN1A Autoantibodies by Cell-Based Immunofluorescence Cytochemistry.
Yamashita S; Tawara N
Methods Mol Biol; 2019; 1901():89-94. PubMed ID: 30539570
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic 5'-nucleotidase autoantibodies in inclusion body myositis: Isotypes and diagnostic utility.
Greenberg SA
Muscle Nerve; 2014 Oct; 50(4):488-92. PubMed ID: 24752512
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic value of anti-cN1A antibodies in inclusion body myositis.
Salam S; Dimachkie MM; Hanna MG; Machado PM
Clin Exp Rheumatol; 2022 Feb; 40(2):384-393. PubMed ID: 35225226
[TBL] [Abstract][Full Text] [Related]
8. Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis.
Lilleker JB; Rietveld A; Pye SR; Mariampillai K; Benveniste O; Peeters MT; Miller JA; Hanna MG; Machado PM; Parton MJ; Gheorghe KR; Badrising UA; Lundberg IE; Sacconi S; Herbert MK; McHugh NJ; Lecky BR; Brierley C; Hilton-Jones D; Lamb JA; Roberts ME; Cooper RG; Saris CG; Pruijn GJ; Chinoy H; van Engelen BG;
Ann Rheum Dis; 2017 May; 76(5):862-868. PubMed ID: 28122761
[TBL] [Abstract][Full Text] [Related]
9. Significance of Sjögren's syndrome and anti-cN1A antibody in myositis patients.
Levy D; Nespola B; Giannini M; Felten R; Severac F; Varoquier C; Rinagel M; Korganow AS; Martin T; Poindron V; Maurier F; Chereih H; Bouldoires B; Hervier B; Lenormand C; Chatelus E; Geny B; Sibilia J; Arnaud L; Gottenberg JE; Meyer A
Rheumatology (Oxford); 2022 Feb; 61(2):756-763. PubMed ID: 33974078
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis.
Pluk H; van Hoeve BJ; van Dooren SH; Stammen-Vogelzangs J; van der Heijden A; Schelhaas HJ; Verbeek MM; Badrising UA; Arnardottir S; Gheorghe K; Lundberg IE; Boelens WC; van Engelen BG; Pruijn GJ
Ann Neurol; 2013 Mar; 73(3):397-407. PubMed ID: 23460448
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Accuracy of Anti-CN1A on the Diagnosis of Inclusion Body Myositis. A Hierarchical Bivariate and Bayesian Meta-analysis.
Mavroudis I; Knights M; Petridis F; Chatzikonstantinou S; Karantali E; Kazis D
J Clin Neuromuscul Dis; 2021 Sep; 23(1):31-38. PubMed ID: 34431799
[TBL] [Abstract][Full Text] [Related]
12. Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases.
Herbert MK; Stammen-Vogelzangs J; Verbeek MM; Rietveld A; Lundberg IE; Chinoy H; Lamb JA; Cooper RG; Roberts M; Badrising UA; De Bleecker JL; Machado PM; Hanna MG; Plestilova L; Vencovsky J; van Engelen BG; Pruijn GJ
Ann Rheum Dis; 2016 Apr; 75(4):696-701. PubMed ID: 25714931
[TBL] [Abstract][Full Text] [Related]
13. Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis.
Amlani A; Choi MY; Tarnopolsky M; Brady L; Clarke AE; Garcia-De La Torre I; Mahler M; Schmeling H; Barber CE; Jung M; Fritzler MJ
Front Immunol; 2019; 10():745. PubMed ID: 31024569
[No Abstract] [Full Text] [Related]
14. Clinical utility of anti-cytosolic 5'-nucleotidase 1A antibody in idiopathic inflammatory myopathies.
Ikenaga C; Findlay AR; Goyal NA; Robinson S; Cauchi J; Hussain Y; Wang LH; Kershen JC; Beson BA; Wallendorf M; Bucelli RC; Mozaffar T; Pestronk A; Weihl CC
Ann Clin Transl Neurol; 2021 Mar; 8(3):571-578. PubMed ID: 33556224
[TBL] [Abstract][Full Text] [Related]
15. Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis.
Lucchini M; Maggi L; Pegoraro E; Filosto M; Rodolico C; Antonini G; Garibaldi M; Valentino ML; Siciliano G; Tasca G; De Arcangelis V; De Fino C; Mirabella M
Cells; 2021 May; 10(5):. PubMed ID: 34068623
[TBL] [Abstract][Full Text] [Related]
16. Myositis-related autoantibody profile and clinical characteristics stratified by anti-cytosolic 5'-nucleotidase 1A status in connective tissue diseases.
Diederichsen LP; Iversen LV; Nielsen CT; Jacobsen S; Hermansen ML; Witting N; Cortes R; Korsholm SS; Krogager ME; Friis T
Muscle Nerve; 2023 Jul; 68(1):73-80. PubMed ID: 37177880
[TBL] [Abstract][Full Text] [Related]
17. Positive Cytosolic 5-Nucleotidase 1A Antibodies in Motor Neuron Disease.
Assadi RK; Manousakis G
J Clin Neuromuscul Dis; 2020 Sep; 22(1):50-52. PubMed ID: 32833724
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus Erythematosus.
Rietveld A; van den Hoogen LL; Bizzaro N; Blokland SLM; Dähnrich C; Gottenberg JE; Houen G; Johannsen N; Mandl T; Meyer A; Nielsen CT; Olsson P; van Roon J; Schlumberger W; van Engelen BGM; Saris CGJ; Pruijn GJM
Front Immunol; 2018; 9():1200. PubMed ID: 29922285
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic role of anti-cN1A autoantibodies in sporadic inclusion body myositis.
Yamashita S; Tawara N; Zhang Z; Nakane S; Sugie K; Suzuki N; Nishino I; Aoki M
J Neurol Neurosurg Psychiatry; 2023 Dec; 94(12):1018-1024. PubMed ID: 37451693
[TBL] [Abstract][Full Text] [Related]
20. [Sporadic Inclusion Body Myositis and Autoantibodies].
Yamashita S; Ando Y
Brain Nerve; 2018 Apr; 70(4):449-457. PubMed ID: 29632292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
